Treatment experiences can be different for everyone

CABLIVI can cause side effects.

In clinical studies, severe bleeding adverse reactions of nosebleed, bleeding from the gums, bleeding in the stomach or intestines, and bleeding from the uterus were each reported in 1% of people.

In the post-marketing setting, cases of life-threatening and fatal bleeding were reported in patients receiving CABLIVI. Contact your doctor immediately if symptoms of excessive bruising, excessive bleeding, or major bleeding occur.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of CABLIVI. Call your doctor for medical advice about side effects.

  • Signs and symptoms of bleeding include: pain, swelling or discomfort, prolonged bleeding from cuts, increased menstrual flow or vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or dark brown urine, red or tar black stools, headache, dizziness, or weakness
  • You may have a higher risk of bleeding if you have a bleeding disorder, such as hemophilia, or take other medicines that increase the risk of bleeding, such as anticoagulants and antiplatelet agents
  • CABLIVI should be stopped for 7 days before surgery or any medical or dental procedure. Talk to your doctor before you stop taking CABLIVI

CABLIVI side effects may include:

  • Bleeding from gums

  • Nosebleeds

  • Headache

  • Anal bleeding

  • Hemorrhoids

  • Fever

  • Tiredness

  • Muscle pain

  • Rash

  • Blood in urine

  • Unusually heavy periods

  • Vaginal bleeding

  • Shortness of breath

  • Injection site reactions (rash, bleeding, itching)

Please see the full list of side effects within the full Prescribing Information for CABLIVI. Talk with your doctor if you have any questions or if you have a side effect that does not go away.

Reporting side effects

If you have side effects, including ones not listed above, talk to your doctor right away.
You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Real people take on aTTP/iTTP with CABLIVI in combination with PEX and immunosuppression
 

Making the most of your treatment

 

aTTP/iTTP=acquired/immune-mediated thrombotic thrombocytopenic purpura.

IMPORTANT SAFETY INFORMATION AND INDICATIONS